New pyrimidine compounds may lead to improved treatments for childhood brain cancer
Tuesday, April 6, 2010 - 14:28
in Health & Medicine
Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. Src represents one of the most promising targets for cancer therapy.